News

Deal Announcements

Calistoga Keeps $30 Million Series B Round

Thursday, May 7, 2009 5:38:00 AM PDT | VentureDeal Staff
Seattle, Washington  --  Pharmaceutical company Calistoga Pharmaceuticals has secured $30 million in its second round of institutional venture capital financing.

Calistoga is developing drug candidates that have the potential to treat various forms of cancer.

Investors in the round included Alta Partners, Amgen Ventures, Frazier Healthcare Ventures and Three Arch Partners. The company said it would use the funding to advance its drug development pipeline.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1